The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.
Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently ...
GlobalData on MSN3d
FDA breakthrough status for Bluejay’s CHD therapy brelovitugThe US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human ...
Brelovitug has previously received Orphan and PRIME designation from the European Medicines Agency.
Nuvalent, Inc. shares have fallen approximately 30% after promising updates on its two lead NSCLC candidates rallied the ...
Cold Fusion on MSN2d
BREAKTHROUGH: Scientists Reverse Blindness [CRISPR Technology]Prince Harry embarks on a new courtroom battle against British tabloids in his case against Rupert Murdoch’s News Group ...
News Medical on MSN10h
Breakthrough gene discovery offers new hope for medulloblastoma therapyScientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy ...
Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback